Your browser doesn't support javascript.
loading
Phase I Study of Afatinib and Selumetinib in Patients with KRAS-Mutated Colorectal, Non-Small Cell Lung, and Pancreatic Cancer.
van Brummelen, Emilie M J; Huijberts, Sanne; van Herpen, Carla; Desar, Ingrid; Opdam, Frans; van Geel, Robin; Marchetti, Serena; Steeghs, Neeltje; Monkhorst, Kim; Thijssen, Bas; Rosing, Hilde; Huitema, Alwin; Beijnen, Jos; Bernards, Rene; Schellens, Jan.
Afiliação
  • van Brummelen EMJ; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Huijberts S; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van Herpen C; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Desar I; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Opdam F; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van Geel R; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Marchetti S; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Steeghs N; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Monkhorst K; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Thijssen B; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Rosing H; Department of Pharmacy, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Huitema A; Department of Pharmacy, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Beijnen J; Department of Pharmacy, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Bernards R; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Schellens J; Department of Pharmacy, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Oncologist ; 26(4): 290-e545, 2021 04.
Article em En | MEDLINE | ID: mdl-33296125

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Neoplasias Colorretais / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Neoplasias Colorretais / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article